Levocarnitine/Trimetazidine Hydrochloride

左卡尼汀/曲美他嗪

Report date: 2025/07/25 14:29:46

Base Information

Drug NameLevocarnitine/Trimetazidine Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCarnitine acetylase stimulantsAcetyl-CoA C-acyltransferase inhibitors
TargetsCarnitine acetylaseAcetyl-CoA C-acyltransferase
Therapy Area/IndicationsHypoxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes LevocarnitineTrimetazidine Hydrochloride
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChangzhou Shanmei Pharmaceutical Res Dev Ct Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Shanmei Pharmaceutical Res Dev Ct Co Ltd
Inactive CompaniesN/A
Active IndicationsHypoxia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A